Regulatory News
Wednesday, September 21, 2016
BRIEF-Epizyme collaborates with Foundation Medicine for tazemetostat phase 2 clinical trial
* Epizyme establishes collaboration with Foundation Medicine
to support tazemetostat phase 2 clinical trial
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment